Research Radartracking 209 published studies · 52 human · 18 clinical trials · 25 cancer pages · updated Jun 2026Open the Research Map →

Research Radar

New PubMed studies on repurposed drugs and natural compounds in cancer — summarized in plain language and reviewed by a person before posting.

How to read this page. These studies are automatically collected from PubMed and summarized by AI from the abstract, then reviewed by a human before publishing. Each summary describes only what that study reported — most are early lab, animal, or small human studies, and findings often conflict. This is educational information, not medical advice, and not a recommendation to take anything. Always talk with your oncologist.
Topic tags. Each study is filed under its main topic. Anticancer studies are the default; these tags flag the other dimensions:
SafetySafety & interactionsAbsorption (PK)How it's absorbed (PK)FormulationFormulation & deliverySupportive careSymptom & supportive careMetabolismMetabolism & pathwaysTrialClinical trialMechanismBiomarker & mechanism
Showing studies that mention prostate adenocarcinoma.
1 of 200 studies
Human · observationalMixed resultsLimited evidenceTier 3 · early humann = 2

Small cell carcinoma of the bladder with coexisting prostate adenocarcinoma: two cases report and literature review

BMC urology · Aug 2020 · case reports (two cases) with literature review

small cell carcinoma of the bladderprostate adenocarcinoma

This paper reports two male patients (ages 72 and 58) who presented with gross hematuria and bladder lesions on MRI. Pathology after radical cystectomy and prostatectomy showed concurrent primary small cell carcinoma of the bladder and prostate adenocarcinoma. One patient died of liver and lung metastases 8 months after surgery; the other was alive at 19 months of follow-up.

Reported effects: patient ages 72 · time to death or follow-up 8 mo

Key findings
  • Two aged males (72 and 582years) presented with gross hematuria and bladder lesions on MRI.
  • Pathological examination after radical cystectomy and prostatectomy showed concurrence of small cell carcinoma of the bladder (SCCB) and prostate adenocarcinoma in both patients.
  • One patient died of liver and lung metastasis 8 months after surgery; the other patient was still alive after 192months of follow-up.
  • The coexistence of SCCB and prostate adenocarcinoma is extremely rare; the paper also includes a literature review on epidemiology, clinical/pathologic features, diagnosis, treatment and prognosis of SCCB.
Limitations: Very small sample size (two cases).; Case-report design; observational and descriptive without controls.; Limited follow-up (one patient followed 8 months, the other 19 months) and limited outcome detail.; No detailed treatment/outcome comparisons or generalizable effectiveness data..

AI summary of the abstract, human-reviewed · Jun 2026. Describes what this study reported, not medical advice. View on PubMed · Full text